Analysis: Novartis will survive Zelnorm
Science Daily (press release) - 3 hours ago
Analysis: Novartis OK despite Galvus delay (February 28, 2007) -- The Food and Drug Administration has requested more clinical data on the safety of ...
Analysis: Novartis will survive Zelnorm United Press International
Novartis stock sags after Zelnorm drug is pulled Therapeutics Daily (subscription) (press release)
Novartis pulls Zelnorm in US, cuts 2007 outlook Therapeutics Daily (subscription) (press release)
Pharma Times (subscription) - Forbes
all 85 news articles